Picture of Erasca logo

ERAS Erasca Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Annual cashflow statement for Erasca, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-123-243-125-162-125
Depreciation
Non-Cash Items34.612119.346.729.3
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital7.7115.80.8131.74-3.33
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities-79.6-103-101-109-95.5
Capital Expenditures-11.2-14.6-1.77-0.06-0.128
Purchase of Fixed Assets
Other Investing Cash Flow Items-53.4-56.5-89.4-157101
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-64.6-71.1-91.2-157100
Financing Cash Flow Items0.5530
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities43998.11.292411.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash295-76.3-191-25.36.07